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Abstract
Background: Epi-testosterone (epiT) is the 17α-epimer of testosterone. It has been found at
similar level as testosterone in human biological fluids. This steroid has thus been used as a natural
internal standard for assessing testosterone abuse in sports. EpiT has been also shown to
accumulate in mammary cyst fluid and in human prostate. It was found to possess antiandrogenic
activity as well as neuroprotective effects. So far, the exact pathway leading to the formation of
epiT has not been elucidated.
Results: In this report, we describe the isolation and characterization of the enzyme 17α-
hydroxysteroid dehydrogenase. The name is given according to its most potent activity. Using cells
stably expressing the enzyme, we show that 17α-HSD catalyzes efficienty the transformation of 4-
androstenedione (4-dione), dehydroepiandrosterone (DHEA), 5α-androstane-3,17-dione (5α-
dione) and androsterone (ADT) into their corresponding 17α-hydroxy-steroids : epiT, 5-
androstene-3β,17α-diol (epi5diol), 5α-androstane-17α-ol-3-one (epiDHT) and 5α-androstane-
3α,17α-diol (epi3α-diol), respectively. Similar to other members of the aldo-keto reductase family
that possess the ability to reduce the keto-group into hydroxyl-group at different position on the
steroid nucleus, 17α-HSD could also catalyze the transformation of DHT, 5α-dione, and 5α-
pregnane-3,20-dione (DHP) into 3α-diol, ADT and 5α-pregnane-3α-ol-20-one (allopregnanolone)
through its less potent 3α-HSD activity. We also have over-expressed the 17α-HSD in Escherichia
coli and have purified it by affinity chromatography. The purified enzyme exhibits the same catalytic
properties that have been observed with cultured HEK-293 stably transfected cells. Using
quantitative Realtime-PCR to study tissue distribution of this enzyme in the mouse, we observed
that it is expressed at very high levels in the kidney.
Conclusion: The present study permits to clarify the biosynthesis pathway of epiT. It also offers
the opportunity to study gene regulation and function of this enzyme. Further study in human will
allow a better comprehension about the use of epiT in drug abuse testing; it will also help to clarify
the importance of its accumulation in breast cyst fluid and prostate, as well as its potential role as
natural antiandrogen.
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Epitestosterone (17α-hydroxy-4-androstene-3-one) is an
epimer of testosterone (T). Its concentration in the urine
is used as reference substance in the control of T abuse [1].
EpiT was identified for the first time as an androgen
metabolite produced by rabbit liver slices [2]. It has been
also observed that slices of rabbit, guinea pig and dog
liver, mare's ovary, ox and sheep blood as well as guinea
pig kidney, ovary and testis possess the ability to produce
epiT from T and 4-dione [3]. In the mouse, the kidney is a
major site of epiT formation, while the production in the
liver is negligible [4]. In castrated male bovine, it has been
observed that blood and liver both possess a high ability
to convert T into epiT [5]. No interconversion of T and
epiT has been observed in testes of bulls, rabbits or rats,
even though it has been found that testes is a source of
endogenous epiT in these species [3].
In young boys, the concentration of epiT is higher than T,
however it declines in adulthood to a epiT/T ratio of
approximately 1 [6]. In hyperplasic prostate, epiT concen-
tration is comparable to that of 4-dione, which represents
about twice the amount of T and half the concentration of
dihydrotestosterone (DHT) [7]. The excretion of epiT in
urine is slightly lower than that of T [8-11]. Plasma con-
centrations of epiT decline with age and were established
at approximately 2.5 nmol/l in adult men and 1.2 nmol/l
in women. Since epiT does not originate from endog-
enous T, and because the ratio of urinary T to epiT in
adults is almost constant, this ratio has been used as a
basis for the detection of exogenously administered T : the
median ratio in normal healthy men is about 1, while
being significantly elevated in case of testosterone abuse.
Urinary T/epiT ratio from 1 to 6 is considered normal by
the International Olympic Committee, while one display-
ing a ratio greater than 6 is suspected of anabolic steroid
use [12]. In order to apply this assay, it is important to
assume that the biosynthesis of epitestosterone does not
originate from testosterone, and that both epimers
undergo similar clearance. It is also important to assume
that racial or individual variations do not affect this ratio.
Because of these important assumptions, parameters that
may influence this ratio and possibly lead to false positive
results have been intensively debated since the introduc-
tion of the T/epiT ratio in doping analysis [13]. The lack
of knowledge about the gene encoding the enzyme
responsible for the formation of epiT has made the iden-
tification of appropriate parameters difficult.
In humans, the interconversion of T and epiT is negligible
[14]. Using labeled-T, it has been shown that epiT does
not originate from T. Studying the 16-ene-synthetase reac-
tion in human testicular homogenates, Weusten et al. [15]
hypothesized that 5-androstene-3β,17α-diol (epi5-diol)
and 5,16-androstadien-3β-ol are synthesized from preg-
nenolone in a single step through a 16-ene-synthase, and
then that epi5-diol is further converted to epiT by 3β-
hydroxysteroid dehydrogenase (3β-HSD). On the other
hand, a recent study showed that administration of 4-
dione to healthy male subjects increases the urinary excre-
tion rates of epiT, thus suggesting that epiT could be bio-
synthesized from 4-dione [16]. The authors suggested that
a likely candidate to convert 4-dione to epiT would be
17α-hydroxysteroid dehydrogenase (17α-HSD). This
enzyme has been purified from liver and kidney tissue
from rabbits and hamsters [17-19]. Accordingly, in this
report, we describe the isolation and characterization of a
cDNA encoding an enzyme exhibiting a strong 17α-HSD
acivity, efficiently catalyzing the conversion of 4-dione
into epiT.
Results
Characterization of mouse 17α-HSD cDNA and gene
The mouse genome project has made available the
sequence of a cluster containing eight members of the
aldo-keto reductase family located in the chromosome 13
[20]. Using specific primers, we have cloned a cDNA frag-
ment containing the entire coding region of the gene iden-
tified as AKR1C21 without notification of any activity.
Sequence analysis of the cDNA fragment shows that it
encodes a putative protein of 323 amino acids having a
calculated MW of 36745 Daltons. We have deposited the
sequence in GenBank under the accession number
AY742217. Comparison of the deduced amino acid
sequence with that of other aldo-keto reductase members
(Figure 1) shows that mouse 17α-HSD shares 77, 70 and
72 % amino acid sequence identity with mouse type 5
17β-HSD, 3α-HSD and 20α-HSD respectively. It also
shares 70, 69, 71, 72, 72, 73, 74 % with rat 3α-HSD and
20α-HSD, rabbit 20α-HSD as well as human 3α-HSD1,
17β-HSD5, 3α-HSD3 and 20α-HSD. The genomic struc-
ture as derived from public data bank indicates that
mouse 17α-HSD gene is 12.5 kb long covering 9 exons
and is transcribed into a 1.2 kb mRNA.
Identification of epiT by HPLC
Preliminary data using [14C]4-dione as substrate showed
that the product resulting from the transformation of 4-
dione by the enzyme overexpressed in HEK-293 cells is
different from T, the metabolite produced by a 17β-HSD
activity. To verify the identity of this metabolite, we used
HPLC to analyze extracts of culture medium of HEK-293
cells over expressing 17α-HSD in presence of [14C]4-dione
(Figure 2B). We also analyzed metabolites obtained after
[14C]4-dione incubation with the pure enzyme (Figure
2C). Comparison of the HPLC elution and TLC migration
profile of the product with a commercial epiT standard
clearly indicates that the product is epitestosterone, the
17α-epimer of testosterone. Using TLC separation, we
were also able to verify the identity of epi3α-diol, which isPage 2 of 11
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order to confirm the 17α-HSD nature of the activity, com-
parison of the products obtained from incubation of 4-
dione (Figure 3A) and ADT (Figure 3B) with 17β-HSD
type 5 and 17α-HSD was accomplished.
Substrate specificity of the mouse 17α-HSD activity
Using 17α-HSD stably expressed in HEK-293 cells, we
have characterized the substrate specificity of this enzyme
in cultured cells by comparison with non transfected cells.
As illustrated in Figure 4 and Table 1, mouse 17α-HSD
possesses two activities. The strongest activity is 17α-
reductase activity responsible for the transformation of 4-
dione into epiT as well as the transformation of ADT, 5α-
dione and DHEA into epi3α-diol, epiDHT and epi5-diol,
respectively. The second activity is 3α-reductase, responsi-
ble for the transformation of DHT to 3α-diol, 5α-dione to
Alignment of the amino acid sequence of mouse 17α-HSD with those of related enzymesFigure 1
Alignment of the amino acid sequence of mouse 17α-HSD with those of related enzymes. Amino acid sequence of 
mouse 17α-HSD was aligned with sequences of mouse (m), rat (r), rabbit (rb) and human (h) enzyme members of the AKR1c 
subfamily. The corresponding name according to the nomenclature for aldo-keto reductase (AKR) family members are: m17α-
HSD, AKR1C21; m3α-HSD, AKR1C14; m20α-HSD, AKR1C18; m17β-HSD5, AKR1C6; r3α-HSD, AKR1C9; r20α-HSD, 
AKR1C8; h3α-HSD1, AKR1C4; h3α-HSD3, AKR1C2; h17β-HSD5 or 3α-HSD2, AKR1C3; and h20α-HSD, AKR1C1. Amino 
acids are given in conventional single letter code and numbered on the right. Dashes and dots, respectively, represent identical 
and missing amino acids.Page 3 of 11
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BMC Biochemistry 2005, 6:12 http://www.biomedcentral.com/1471-2091/6/12Identification by HPLC of epiT produced from HEK-293 cells stably expressing 17α-HSDFigure 2
Identification by HPLC of epiT produced from HEK-293 cells stably expressing 17α-HSD. (A) Elution profile of 
non labeled steroids; 4-dione (1st peak), testosterone (2nd peak) and epitestosterone (3rd peak). (B) Products extracted from 
enzymatic assay done with cells stably expressing 17α-HSD, substrate is 4-dione. (C) Products extracted from enzymatic assay 
done with purified enzyme; substrate is 4-dione. Separation and identification of metabolites were performed as described in 
Materials and Methods.Page 4 of 11
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that purified enzyme displays the same catalytic activity as
the overexpressed enzyme in intact cells.
Tissue distribution of mouse 17α-HSD
Using Q_RT-PCR to quantify mRNA expression levels of
17α-HSD in male and female (Table 2) mouse tissues, we
found that the expression of this enzyme is highly specific
for the mouse kidney, while type 5 17β-HSD, the enzyme
catalyzing the formation of T, is markedly expressed in the
liver. Both enzymes are expressed at very high levels, more
than 15 millions copies/µg total RNA. Since the estimated
amount of total RNA in a single liver cell is about 50 pg
[21], we consider that an expression level of 20,000 cop-
ies/µg total RNA corresponds to approximately 1 copy/
cell in an homogenous cell population. Therefore, 15 mil-
lions copies/µg total RNA should correspond to 750
copies/cell.
Discussion
The present report describes the isolation and characteri-
zation of a cDNA sequence encoding the enzyme 17α-
HSD. We have shown that this enzyme converts mainly
17-ketosteroids into 17α-hydroxysteroids : 4-dione to
epiT, ADT to epi3α-diol, 5α-dione to epiDHT and DHEA
to epi5-diol. Since the enzyme is able to catalyze 4 dis-
tincts 17-ketosteroids into its 17α-hydroxy-compounds,
and because all the four products have shown identitical
profile on HPLC and TLC with commercial products, the
results, thus, represent a strong evidence that the activity
catalyzed by this specific enzyme is a 17-ketoreductase
activity producing 17α-hydroxysteroids.
17α-HSD belongs to the aldo-keto reductase family and
shares 77 % amino acid with the mouse type 5 17β-HSD,
an enzyme catalyzing the transformation of 4-dione into
T [22]. To our knowledge, this is the first example of two
highly homologous enzymes belonging to the same gene
family, and catalyzing the formation of two distinct epim-
ers from a same substrate. This will represent an interest-
ing model to study the mechanism of the 17α- and 17β-
stereospecificity. In addition to the difference in substrate
specificity, mouse 17α-HSD and 17β-HSD5 show distinct
and specific mRNA tissue distribution : 17α-HSD is highly
Identification of the 17α-HSD activity by TLCFigure 3
Identification of the 17α-HSD activity by TLC. A- Incubation of [14C]-4-dione with cells stably expressing mouse 17β-
HSD type 5 (1) and 17α-HSD (2) activity. Standards of 4-dione (3), T (4) and epiT (5) have been deposited and co-migrated. B- 
Incubation of [14C]-ADT with cells cells stably expressing mouse 17β-HSD type 5 (1) and 17α-HSD (2) activity. Standards of 
ADT (3), 3α-diol (4) and epi3α-diol (5) have been deposited and co-migrated.Page 5 of 11
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liver. This is in agreement with previous reports showing
that mouse liver does not produce epiT [3].
We have previously shown that mouse type 5 17β-HSD is
specifically expressed in the liver [22], while human type
5 17β-HSD is more widely expressed [23]. It is noteworthy
that 17α-HSD and type 5 17β-HSD belongs to aldo-keto
reductase family. Members of this family share very high
homology although they catalyze different activities and
are expressed in different tissues; for example, mouse type
5 17β-HSD shares 77, 88 and 86 % identity with mouse
17α-HSD, 3α-HSD and 20α-HSD respectively. Therefore,
previous studies based on hybridation experiments such
as northern blot analysis could not distinguish different
members of the aldo-keto-reductase family. Using
Substrate specificity of mouse 17α-HSD activity of HEK-293 cells stably transfected with pCMVneo-m17α-HSDFigure 4
Substrate specificity of mouse 17α-HSD activity of HEK-293 cells stably transfected with pCMVneo-m17α-
HSD. The experiments were performed using HEK-293 cells stably expressing 17α-HSD in culture. 0,1 µM of the indicated 
[14C]-and [3H]-labeled steroid was added to culture medium for one hour. Testo, conversion of testosterone to 4-dione and 
vice-versa; E1, conversion of estrone to estradiol and vice-versa; DHEA, conversion of dehydroepiandrosterone to 5-diol; 5α-
dione, conversion of androstanedione to androsterone (ADT) and vice-versa; DHT, conversion of dihydrotestosterone to 3α-
diol and vice-versa; DHP, conversion of dihydroprogesterone to allopregnanolone and vice-versa; Preg and Prog, conversion of 
pregnenolone and progesterone to 20α-OHPreg and 20α-OHProg. The error bar indicates mean ± SEM of triplicate assays. 
Incubation, extraction, separation and quantification were performed as described in Materials and Methods.
Table 1: Kinetic constants of 17α-HSD for various substrates
Km (µM) Vmax (µmol/min) Vmax / Km
4-dione 0,4 0,3 0,7
ADT 0,9 0,3 0,3
DHEA 3,5 0,4 0,1
DHT 2,0 0,7 0,3Page 6 of 11
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present manuscript, mouse type 5 17β-HSD could be spe-
cifically identified, distinctly from 17α-HSD.
Our results show that 17α-HSD is able to convert 4-dione
to epiT as well as DHEA to epi5α-diol, and thus suggest
that epiT could be produced through two different path-
ways involving 17α-HSD (Figure 5). However, the cata-
lytic efficiency of 3β-HSD and 17α-HSD for DHEA and 4-
dione respectively, strongly suggest that the main pathway
leading to the formation of epiT is the conversion of
DHEA by 3β-HSD and the 4-dione product being further
converted into epiT. In a previous study described by
Weusten et al. [15], it was shown that a non-negligible
quantity of epi5-diol is produced by 16-ene-synthase
activity, the reaction catalyzing the transformation of
pregnenolone into 5,16-androstadien-3β-ol. The authors
thus suggested that epi5-diol could be produced directly
from pregnenolone, and epiT being produced by the sub-
sequent conversion of epi5-diol by 3β-HSD. In contrast,
our data strongly suggests that the epi5-diol originates
from the transformation of pregnenolone to DHEA by
P450c17, followed by the conversion of DHEA into epi5-
diol by the enzyme 17α-HSD. Previously, we have shown
that P450c17 possesses two activities, 17α-hydroxylase/
17-20 lyase and 16-ene synthase, that are able to convert
pregnenolone into DHEA and 5,16-androstadien-3β-ol,
respectively [24]; however, no epi5-diol has been
detected.
The present first report of 17α-HSD will help to better
understand the physiological role of epiT. It offers a tool
to further study at molecular level the role of 17α-HSD in
human, espectially for T abuse testing in sports using epiT
as a control. It also permits to investigate the importance
of epitestosterone in some previously reported interesting
phenomenons such as its accumulation in mammary cyst
fluid [25] and in human prostate [7,26], as well as its
potential neuroprotective effects [27], and natural anti-
androgenic effects [28].
Methods
Isolation of mouse 17α-HSD
A cDNA fragment of a coding region of mouse 17α-HSD
(AKR1C21) was amplified by polymerase chain reaction
(PCR) from a mouse spleen cDNA and the oligoprimer
pair (5'-ggg-gtc-gac-ttt-gaa-gag-gga-cac-ata-atg-a-3' and 5'-
ggg-ggt-acc-acc-cat-agg-ctt-ttc-agg-aga-3') derived from the
DNA sequence NM_029901 from GenBank database.
Mouse spleen cDNA was obtained by reverse transcription
of 20 µg of mouse spleen total RNA using 400 U Super-
Script II reverse transcriptase (Invitrogen, Burlington,
Ontario, Canada) and oligo-d(T)24 as primer in a reac-
tion buffer containing 50 mM Tris-HCl pH 8.3, 75 mM
KCl, 3 mM MgCl2, 10 mM DTT and 0.5 mM dNTPs. The
resulting cDNA fragments were subcloned into a pCMV-
neo expression vector (pCMVneo-m17α-HSD) which was
subsequently used to produce a stably transfected HEK-
293 cell line. Plasmid DNA was prepared using the
Table 2: Quantification of mRNA expression levels of 17α-HSD and 17β-HSD5 in various mouse tissues using Realtime PCR
17α-HSD (number of copies/µg RNA ± SEM) 17β-HSD5 (number of copies/µg RNA ± SEM)
male female male female
Pituitary gland 130 ± 92 692 ± 251 572 ± 992 2986 ± 2591
Adrenal 0 ± 0 12036 ± 356 53445 ± 11410 3714 ± 1960
Liver 2344 ± 6 332 ± 73 15369159 ± 2701597 14995082 ± 987906
Kidney 22226386 ± 1068282 17083578 ± 928740 45536 ± 9194 102586 ± 35774
Spleen 21610 ± 1369 7466 ± 438 22791 ± 4358 8777 ± 5673
Lung 0 ± 0 0 ± 0 0 ± 0 6097 ± 2642
Thymus 2029 ± 40 3790 ± 134 407 ± 705 10943 ± 7200
Stomach 0 ± 0 0 ± 0 11858 ± 4062 8539 ± 4606
Colon 13860 ± 2184 6299 ± 1049 256686 ± 37628 17438 ± 21120
Heart 0 ± 0 0 ± 0 0 ± 0 6821 ± 4402
Testis 6333 ± 490 - 0 ± 0 -
Prostate 0 ± 0 - 1095 ± 1896 -
Preputial gland 2681 ± 261 - 14551 ± 12605 -
Ovary - 1980 ± 120 - 7208 ± 6397
Uterus - 0 ± 0 - 8328 ± 3819
Clitoral gland - 6516 ± 337 - 14419 ± 12591
Mammary gland - 0 ± 0 - 5666 ± 3188Page 7 of 11
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Sequence of the pCMVneo-m17α-HSD was determined
using an ABI 3730/XL automatic sequencer, to verify the
identity of the amplified sequence.
Stable expression in HEK-293 cells
Stable transfection of pCMVneo-m17α-HSD into HEK-
293 cells was performed as described previously [29].
Briefly, HEK-293 cells were cultured in 6-well falcon flasks
to approximately 3 × 105 cells/well in Minimum Essential
Medium (MEM) (Invitrogen) supplemented with 10%
(vol/vol) FCS (Wisent, Saint-Bruno, Québec, Canada) at
37°C under a 95% air- 5% CO2 humidified atmosphere.
Five µg of pCMVneo-m17α-HSD was transfected using
Exgen 500 reagent (Fermentas, Burlington, Ontario, Can-
ada). After 6 h incubation at 37°C, the transfection
medium was removed and 2 ml of MEM were added. Cells
were further cultured for 48 h, then transferred into 10 cm
Petri dishes and cultured in MEM containing 700 µg/ml of
G-418 (Invitrogen) in order to inhibit the growth of non-
Diagram illustrating the 2 putative pathways for the conversion of DHEA to epiT via 17α-HSD and 3β-HSDFigure 5
Diagram illustrating the 2 putative pathways for the conversion of DHEA to epiT via 17α-HSD and 3β-HSD. 
The thickness of the arrows indicates the relative importance of each pathwayPage 8 of 11
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changed every two days until resistant colonies were
observed.
Overexpression and purification of mouse 17α-HSD
The cDNA encoding mouse 17α-HSD was subcloned into
a pGEX vector (Amhersham Biosciences, Baie d'Urfé,
Québec, Canada) and expressed in Escherichia coli
BL21(DE3) pLysS as a fusion protein with glutathione-S-
transferase (GST). The fusion protein was isolated using a
Glutathione-Sepharose 4B column, as described by the
manufacturer. The purified 17α-HSD enzyme was sepa-
rated from GST by digestion with thrombin. 17α-HSD is
not adsorbed on the DEAE column and is recuperated in
the flow-through fraction, while GST and fusion protein
remain on the column. With this method we obtain about
10 mg of a purified enzyme preparation per 100 ml of cell
culture. Analysis of samples obtained during the purifica-
tion process was performed using sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE), as
described before [30]. The broad range molecular weight
standards was purchased from Bio-Rad (Missisauga,
Ontario, Canada).
Assay of enzymatic activity
Enzymatic activities of 17α-HSD were determined using
both purified enzyme and the cultured HEK-293 cells sta-
bly transfected with pCMVneo-m17α-HSD, as previously
described [29]. Briefly, 3 µg of purified 17α-HSD were
incubated with 10 mM NADPH, 0.1 µM of 4-dione in
phosphate saline buffer, 50 mM, pH 7.3, for 20 minutes.
For the intact cells, 0.1 µM of the [14C]-labeled steroid
(PerkinElmer, Boston, Massachussetts, USA) was added to
freshly changed culture medium in a 6-well culture plate.
Non-transfected HEK-293 cells were used as control of the
background. After incubation, the steroids were extracted
with 2 ml of ether. The organic phases were pooled and
evaporated to dryness. The steroids were then solubilized
in 50 µl of dichloromethane, applied to Silica gel 60 thin
layer chromatography (TLC) plates (Merck, Darmstad,
Germany). To obtain a better separation and identifica-
tion of metabolites, different solvent systems were used.
Metabolites of substrates 4-dione, DHEA and 5α-dione
were separated in chloroform : ether (9:1), while DHP,
DHT and ADT products were separated in the toluene :
acetone (4:1) solvent system. Substrates and metabolites
were identified by comparison with reference steroids,
revealed by autoradiography and quantified using the
PhosphorImager System (Molecular Dynamics, Sunny-
vale, California, USA). The enzymatic reaction was carried
out using the condition in which the activity varies line-
arly with the enzyme concentration and incubation time,
indicating that the cofactor concentration produced by
the cells is in excess; the reverse reaction was consequently
prevented. In our conditions, this linearity was observed
at even more than 60% transformation. Determination of
the kinetic parameters was done by Lineweaver-Burk
graph analysis using Enzfitter software.
Identification of epitestosterone by High Performance 
Liquid Chromatography (HPLC)
14C-Labeled steroids were analyzed using Waters NovaPak
reverse-phase C18 HPLC column (3.9 × 150 mm, 4 µm).
The mobile phase was MeOH/H2O/THF (26 : 56 : 18 v/v),
with a flow rate of 0.7 ml.min-1. Radioactivity was moni-
tored in the eluent using Beckman 171 HPLC Radioactiv-
ity Monitoring System. Unlabelled steroids (4-dione,
DHEA, 5α-dione, ADT, T, 5-diol, DHT, 3α-diol, epiT,
epi5-diol, epiDHT and epi3α-diol) were obtained from
Steraloids (Newport, Rhode Island, USA) and used as
standards.
Tissue collection and RNA preparation
Total RNA of indicated tissues was isolated using Trizol
Reagent (Invitrogen, Burlington, Ontario) as described by
the manufacturer. Twenty µg of total RNA was converted
to cDNA by incubation at 42°C for 1 h with 400 U Super-
Script II reverse transcriptase (Invitrogen), using oligo-
d(T)24 as primer in a reaction buffer containing 50 mM
Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM DTT
and 0.5 mM dNTPs. The tissues were collected in C57BL6
mice at 12-15 weeks of age obtained from Charles River,
Inc. (Saint-Constant, Québec, Canada). The mice were
housed individually in vinyl cages. The photoperiod was
12 h of light and 12 h of darkness (lights on at 07:15 h).
Certified rodent food (Lab Rodent Diet) and tap water
were provided ad libitum. The experiment was conducted
in an animal facility approved by the Canadian Council
on Animal Care (CCAC) and the Association for Assess-
ment and Accreditation of Laboratory Animal Care (AAA-
LAC). The study was performed in accordance with the
CCAC Guide for Care and Use of Experimental Animals.
The collected organs were rapidly trimmed, snap-frozen
in liquid nitrogen and stored at -80°C until RNA
extraction.
Tissue distribution of 17α-HSD mRNA using RealTime PCR
Total RNA from pituitary gland, adrenal, liver, kidney,
spleen, thymus, stomach, heart, lung, ovary, uterus, clito-
ral gland, mammary gland, testis, prostate and preputial
gland, prepared as described above, were analyzed for the
expression of 17α-HSD mRNA using quantitative Real-
Time RT-PCR (Q_RTPCR). cDNA corresponding to 20 pg
of the initial total RNA was used to perform fluorescent-
based Realtime PCR quantification using the LightCycler
Realtime PCR apparatus (Roche Inc. Nutley, NJ). Reagents
were obtained from the same company and were used as
described by the manufacturer. The conditions for the
PCR reactions were: denaturation at 95°C for 10 sec,
annealing at 62°C for 5 sec and elongation at 72°C for 8Page 9 of 11
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BMC Biochemistry 2005, 6:12 http://www.biomedcentral.com/1471-2091/6/12sec. Oligoprimer pairs (5'-ttg-att-gcc-ctt-cgc-tac-cag-3', 5'-
aaa-tgg-cag-cag-gta-tgt-atc-gc-3') allowed the amplifica-
tion of approximately 170 bp of the mouse 17α-HSD
sequence. Data calculation and normalization was per-
formed using second derivative and double correction
method as previously described [31]. 17α-HSD mRNA
expression levels are expressed as number of copies/µg
total RNA using a standard curve of Cp versus logarithm
of the quantity. The standard curve was established using
known cDNA amounts of 0, 102, 103, 104, 105 and 106
copies of cDNA and a LightCycler 3.5 program provided
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